Serum metabolomic alterations in multiple myeloma revealed by targeted and untargeted metabolomics approaches: a pilot study

Multiple myeloma (MM) is the second most prevalent hematological malignancy characterized by rapid proliferation of plasma cells, which leads to overproduction of antibodies. MM affects around 15% of all hemato-oncology cases across the world. The present study involves identification of metabolomic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chanukuppa, Venkatesh, More, Tushar H., Taunk, Khushman, Taware, Ravindra, Chatterjee, Tathagata, Sharma, Sanjeevan, Rapole, Srikanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2019
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071903/
https://www.ncbi.nlm.nih.gov/pubmed/35531512
http://dx.doi.org/10.1039/c9ra04458b

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071903/
https://www.ncbi.nlm.nih.gov/pubmed/35531512
http://dx.doi.org/10.1039/c9ra04458b

Ejemplares similares